|
paxil suicide Paxil. Participants in those clinical trials had psychiatric disorders including MDD paxil suicide, other depression paxil suicide, and nondepression disorders. Nearly 9 paxil suicide, 000 were taking Paxil and almost 6 paxil suicide, 000 others were taking a placebo. The analysis showed a higher frequency of suicidal behavior in young adults (aged 18-24) with Paxil compared with placebo paxil suicide, but not in older adults. The age gap was not statistically significant paxil suicide, meaning it may have been due to chance. Another analysis focused on adults of all ages with major depressive disorder. The frequency of suicidal behavior was higher among those taking Paxil than placebo paxil suicide, with 11 cases of suicidal behavior among 3 paxil suicide, 455 patients paxil suicide.
paxil suicide Taking Paxil and one out of 1 paxil suicide, 978 taking placebo. Overall paxil suicide, 0.32% of the Paxil patients of all ages with major depressive disorder showed suicidal behavior paxil suicide, compared with 0.05% of those taking placebo. "All of the reported events of suicidal behavior in the adult patients with MDD were nonfatal suicide attempts paxil suicide, and the majority of these attempts (8 of 11) were in younger adults aged 18-30 paxil suicide, " states GlaxoSmithKline's letter. Caution on the Data The age differences in the frequency of suicidal behavior in adults of all ages with MDD were "statistically significant; however paxil suicide, as the absolute number and incidence of events are small paxil suicide, these data should be interpreted with caution paxil suicide, " states GlaxoSmithKline. Most patients who attempted suicide during the study "had an identified social stressor at the time of the event paxil suicide, " the letter notes. The letter also says that "it is difficult to conclude a causal relationship between paroxetine and suicidality due to the small incidence and absolute number of events paxil suicide, the retrospective nature of this meta-analysis paxil suicide, and potential for confounding by the fact that the events of interest are a symptom of the psychiatric illnesses themselves." GlaxoSmithKline spokespeople were not immediately available for comment. SOURCES: News release paxil suicide, FDA. GlaxoSmithKline paxil suicide, "Dear Healthcare Professional paxil suicide, .
paxil suicide D with caution paxil suicide, " states GlaxoSmithKline. Most patients who attempted suicide during the study "had an identified social stressor at the time of the event paxil suicide, " the letter notes. The letter also says that "it is difficult to conclude a causal relationship between paroxetine and suicidality due to the small incidence and absolute number of events paxil suicide, the retrospective nature of this meta-analysis paxil suicide, and potential for confounding by the fact that the events of interest are a symptom of the psychiatric illnesses themselves." GlaxoSmithKline spokespeople were not immediately available for comment. SOURCES: News release paxil suicide, FDA. GlaxoSmithKline paxil suicide, "Dear Healthcare Professional paxil suicide, ".
paxil suicide 
paxil suicide | | | | | |
paxil suicide
|